DNAprint Genomics (DNAG)

[dgplexus]

The most meaningful measure of an R&D company's success, is the value of the intellectual property that is produced, compared to the funds used. I'm not the only one who considers DNAPrint Genomics a resounding success, in this. The value is becoming increasingly obvious, especially now that Personalized Medicine's day appears to have arrived, even ahead of many projections.

That R&D companies use money, often get stuck with toxic financing, fall victim to blatant stock manipulation, and are often plagued by vultures, should come as no surprise to anyone familiar with such matters.

The harder and more frequently a "dead horse" is flogged, the more it becomes apparent, that the vultures covet it intensely, and that it's no "dead horse," at all, but quite valuable, indeed.

Still not selling a single share,

Daniel